These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3715982)

  • 1. Lack of evidence for a reduction in the efficacy of subcutaneous BCG vaccination in mice infected with nontuberculous mycobacteria.
    Orme IM; Roberts AR; Collins FM
    Tubercle; 1986 Mar; 67(1):41-6. PubMed ID: 3715982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic effect in mice of BCG vaccination against nontuberculous mycobacterial infections.
    Orme IM; Collins FM
    Tubercle; 1985 Jun; 66(2):117-20. PubMed ID: 4024269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does infection with environmental mycobacteria suppress the protective response to subsequent vaccination with BCG?
    Smith D; Reeser P; Musa S
    Tubercle; 1985 Mar; 66(1):17-23. PubMed ID: 3984035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Mycobacterium bovis BCG vaccination in mice undergoing prior pulmonary infection with atypical mycobacteria.
    Orme IM; Collins FM
    Infect Immun; 1984 Apr; 44(1):28-32. PubMed ID: 6423543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
    Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
    J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biologic effect of atypical mycobacteria against a background of BCG vaccination].
    Iablokova TB; Levi DT; Kartsag E; Lazaruk LM
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jan; (1):123-6. PubMed ID: 961227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection with Mycobacterium kansasii and efficacy of vaccination against tuberculosis.
    Orme IM; Collins FM
    Immunology; 1983 Dec; 50(4):581-6. PubMed ID: 6228515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of mice with Mycobacterium leprae/Mycobacterium bovis BCG admixtures: modulation of the acquired response to BCG.
    Orme IM
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):293-8. PubMed ID: 3298475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed mycobacterial infections.
    Weiszfeiler JG; Karasseva V
    Rev Infect Dis; 1981; 3(5):1081-3. PubMed ID: 7339808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LYMPH GLAND PROCESSES CAUSED BY ATYPICAL MYCOBACTERIA AND MYCOBACTERIUM AVIUM. BACTERIOLOGICALLY VERIFIED CASES IN DENMARK FROM 1935 TO 1961.
    ENGBAEK HC
    Acta Tuberc Pneumol Scand; 1964; 44():108-37. PubMed ID: 14165365
    [No Abstract]   [Full Text] [Related]  

  • 12. Neonatal BCG vaccination and mycobacterial cervical adenitis in childhood.
    Katila ML; Brander E; Backman A
    Tubercle; 1987 Dec; 68(4):291-6. PubMed ID: 3138802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.
    Zelmer A; Tanner R; Stylianou E; Damelang T; Morris S; Izzo A; Williams A; Sharpe S; Pepponi I; Walker B; Hokey DA; McShane H; Brennan M; Fletcher H
    BMC Infect Dis; 2016 Aug; 16():412. PubMed ID: 27519524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
    Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
    Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THE EFFECTS IN MICE OF INFECTION WITH GROUP IIIA UNCLASSIFIED MYCOBACTERIA AND BCG ON CHALLENGE INFECTION WITH M. TUBERCULOSIS.
    DUNBAR FP; CACCIATORE R; ARMSTRONG AL
    Am Rev Respir Dis; 1964 Feb; 89():280-3. PubMed ID: 14117691
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
    de Lisle GW; Wards BJ; Buddle BM; Collins DM
    Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCG vaccination and non-tuberculous Mycobacteria.
    Gangadharam PR
    Tubercle; 1981 Sep; 62(3):223-4. PubMed ID: 7314256
    [No Abstract]   [Full Text] [Related]  

  • 19. Strain differences in mouse cellular responses to Mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas.
    Roch F; Bach MA
    Clin Exp Immunol; 1990 Jun; 80(3):332-8. PubMed ID: 2197047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of nontuberculous mycobacteria. A bacteriological survey of Swedish strains isolated between 1973 and 1981.
    Wickman K
    Scand J Infect Dis; 1986; 18(4):337-45. PubMed ID: 3532304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.